The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
63
Design and synthesis of procollagen C-proteinase inhibitors.EBI
Fibrogen
50
Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues.EBI
Roche Bioscience
24
Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.EBI
Pfizer
54
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.EBI
University of Athens
70
Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.EBI
Pfizer
5
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.EBI
Pfizer
44
Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.EBI
Combichem
19
Novel inhibitors of procollagen C-terminal proteinase. Part 1: diamino Acid hydroxamates.EBI
Combichem
79
Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase. Part 2: Solid-phase optimization of side chains.EBI
Roche Bioscience
62
Solid-phase synthesis of di- and tripeptidic hydroxamic acids as inhibitors of procollagen C-proteinase.EBI
Roche Bioscience
19
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.EBI
Glaxosmithkline Pharmaceuticals